AM, S., KD, S., & B, B. (2020). Evaluating Blinatumomab for the Treatment of Relapsed/Refractory ALL: Design, Development, and Place in Therapy. Dove Medical Press.
Chicago Style (17th ed.) CitationAM, Sigmund, Sahasrabudhe KD, and Bhatnagar B. Evaluating Blinatumomab for the Treatment of Relapsed/Refractory ALL: Design, Development, and Place in Therapy. Dove Medical Press, 2020.
MLA (8th ed.) CitationAM, Sigmund, et al. Evaluating Blinatumomab for the Treatment of Relapsed/Refractory ALL: Design, Development, and Place in Therapy. Dove Medical Press, 2020.
Warning: These citations may not always be 100% accurate.